EDP Sciences logo
Search
Menu
All issues Volume 38 / No 4 (July-August 2007) Vet. Res., 38 4 (2007) 547-564 References
Free Access
Issue
Vet. Res.
Volume 38, Number 4, July-August 2007
Page(s) 547 - 564
DOI https://doi.org/10.1051/vetres:2007015
Published online 30 May 2007
How to cite this article Vet. Res. (2007) 547-564
References of  Vet. Res. 38 (2007) 547-564
  1. Bacon K.B., Premack B.A., Gardner P., Schall T.J., Activation of dual T cell signaling pathways by the chemokine RANTES, Science (1995) 269:1727-1730 [CrossRef].
  2. Baneth G., Dank G., Keren-Kornblatt E., Sekeles E., Adini I., Eisenberger C.L., Schnur L.F., King R., Jaffe C.L., Emergence of visceral leishmaniasis in central Israel, Am. J. Trop. Med. Hyg. (1998) 59:722-725 [PubMed].
  3. Belkaid Y., Hoffmann K.F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., Sacks D.L., The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, J. Exp. Med. (2001) 194:1497-1506 [CrossRef] [PubMed].
  4. Bogdan C., Vodovotz Y., Paik J., Xie Q.W., Nathan C., Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages, J. Leukoc. Biol. (1994) 55:227-233 [PubMed].
  5. Borja-Cabrera G.P., Correia Pontes N.N., da Silva V.O., Paraguai de Souza E., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., Palatnik de Sousa C.B., Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN), Vaccine (2002) 20:3277-3284 [CrossRef] [PubMed].
  6. Bourdoiseau G., Bonnefont C., Hoareau E., Boehringer C., Stolle T., Chabanne L., Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs, Vet. Immunol. Immunopathol. (1997) 59:21-30 [PubMed].
  7. Brachelente C., Muller N., Doherr M.G., Sattler U., Welle M., Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response, Vet. Pathol. (2005) 42:166-175 [CrossRef] [PubMed].
  8. Brandonisio O., Panaro M.A., Fumarola I., Sisto M., Leogrande D., Acquafredda A., Spinelli R., Mitolo V., Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages, Clin. Exp. Med. (2002) 2:125-129 [CrossRef] [PubMed].
  9. Brenier-Pinchart M.P., Pelloux H., Derouich-Guergour D., Ambroise-Thomas P., Chemokines in host-protozoan-parasite interactions, Trends Parasitol. (2001) 17:292-296 [CrossRef] [PubMed].
  10. Chamizo C., Moreno J., Alvar J., Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis, Vet. Immunol. Immunopathol. (2005) 103:67-75 [PubMed].
  11. Chatterjee M., Basu K., Basu D., Bannerjee D., Pramanik N., Guha S.K., Goswami R.P., Saha S.K., Mandal C., Distribution of IgG subclasses in antimonial unresponsive Indian kala- azar patients, Clin. Exp. Immunol. (1998) 114:408-413 [PubMed].
  12. Correa A.P., Dossi A.C., de Oliveira Vasconcelos R., Munari D.P., de Lima V.M., Evaluation of transformation growth factor beta(1), interleukin-10, and interferon-gamma in male symptomatic and asymptomatic dogs naturally infected by Leishmania (Leishmania) chagasi, Vet. Parasitol. (2006) 143:267-274 [PubMed].
  13. Cotterell S.E., Engwerda C.R., Kaye P.M., Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner, Eur. J. Immunol. (1999) 29:203-214 [PubMed].
  14. Deplazes P., Smith N.C., Arnold P., Lutz H., Eckert J., Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites, Parasite Immunol. (1995) 17:451-458 [PubMed].
  15. Dorner B.G., Scheffold A., Rolph M.S., Huser M.B., Kaufmann S.H., Radbruch A., Flesch I.E., Kroczek R.A., MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines, Proc. Natl. Acad. Sci. USA (2002) 99:6181-6186 [CrossRef] [PubMed].
  16. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., Luster A.D., IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking, J. Immunol. (2002) 168:3195-3204.
  17. Frangogiannis N.G., Mendoza L.H., Smith C.W., Michael L.H., Entman M.L., Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia, Cell Tissue Res. (2000) 302:365-376 [CrossRef] [PubMed].
  18. Gavagani A.S.M., Mohite H., Edrissian G.H., Mohebali M., Davies C.R., Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum, Am. J. Trop. Med. Hyg. (2002) 67:511-515 [PubMed].
  19. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., Siddig M., Hashim F.A., el Hassan A.M., Russo D.M., Reed S.G., Interleukin 10 production correlates with pathology in human Leishmania donovani infections, J. Clin. Invest. (1993) 92:324-329 [PubMed].
  20. Hailu A., van der Poll T., Berhe N., Kager P.A., Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis, Am. J. Trop. Med. Hyg. (2004) 71:561-567 [PubMed].
  21. Karp C.L., el Safi S.H., Wynn T.A., Satti M.M., Kordofani A.M., Hashim F.A., Hag-Ali M., Neva F.A., Nutman T.B., Sacks D.L., In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma, J. Clin. Invest. (1993) 91:1644-1648 [PubMed].
  22. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., Barrett T.A., Differential CC chemokine-induced enhancement of T helper cell cytokine production, J. Immunol. (1997) 158:4129-4136 [PubMed].
  23. Kenney R.T., Sacks D.L., Gam A.A., Murray H.W., Sundar S., Splenic cytokine responses in Indian kala-azar before and after treatment, J. Infect. Dis. (1998) 177:815-818 [PubMed].
  24. Leandro C., Santos-Gomes G.M., Campino L., Romao P., Cortes S., Rolao N., Gomes-Pereira S., Rica Capela M.J., Abranches P., Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis, Vet. Immunol. Immunopathol. (2001) 79:273-284 [PubMed].
  25. Mazza G., Whiting A.H., Day M.J., Duffus W.P., Development of an enzyme-linked immunosorbent assay for the detection of IgG subclasses in the serum of normal and diseased dogs, Res. Vet. Sci. (1994) 57:133-139 [PubMed].
  26. McMahon-Pratt D., Alexander J., Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev. (2004) 201:206-224.
  27. Miralles G.D., Stoeckle M.Y., McDermott D.F., Finkelman F.D., Murray H.W., Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis, Infect. Immun. (1994) 62:1058-1063 [PubMed].
  28. Noli C., Auxilia S.T., Treatment of canine Old World visceral leishmaniasis: a systematic review, Vet. Dermatol. (2005) 16:213-232 [PubMed].
  29. Peters I.R., Helps C.R., Hall E.J., Day M.J., Real-time RT-PCR: considerations for efficient and sensitive assay design, J. Immunol. Methods (2004) 286:203-217 [CrossRef] [PubMed].
  30. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J., Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time RT-PCR, Vet. Immunol. Immunopathol. (2005) 103:101-111 [PubMed].
  31. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., Kaye P.M., Tissue cytokine responses in canine visceral leishmaniasis, J. Infect. Dis. (2001) 183:1421-1424 [CrossRef] [PubMed].
  32. Quinnell R.J., Courtenay O., Garcez L.M., Kaye P.M., Shaw M.A., Dye C., Day M.J., IgG subclass responses in a longitudinal study of canine visceral leishmaniasis, Vet. Immunol. Immunopathol. (2003) 91:161-168 [PubMed].
  33. Rabin R.L., Park M.K., Liao F., Swofford R., Stephany D., Farber J.M., Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling, J. Immunol. (1999) 162:3840-3850 [PubMed].
  34. Ritter U., Moll H., Laskay T., Brocker E., Velazco O., Becker I., Gillitzer R., Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis, J. Infect. Dis. (1996) 173:699-709 [PubMed].
  35. Rousseau D., Demartino S., Anjuere F., Ferrua B., Fragaki K., Le Fichoux Y., Kubar J., Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge, Eur. Cytokine Netw. (2001) 12:340-347 [PubMed].
  36. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., Silveira H., Cytokine expression during the outcome of canine experimental infection by Leishmania infantum, Vet. Immunol. Immunopathol. (2002) 88:21-30 [PubMed].
  37. Scott P., Natovitz P., Coffman R.L., Pearce E., Sher A., Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens, J. Exp. Med. (1988) 168:1675-1684 [CrossRef] [PubMed].
  38. Solano-Gallego L., Riera C., Roura X., Iniesta L., Gallego M., Valldares J.E., Fisa R., Castillejo S., Alberola J., Ferrer L., Arboix M., Portus M., Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas - Evolution in the course of infection and after treatment, Vet. Parasitol. (2001) 96:265-276 [PubMed].
  39. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Botran R., Coffman R.L., Mosmann T.R., Vitetta E.S., Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells, Nature (1988) 334:255-258 [CrossRef] [PubMed].
  40. Strauss-Ayali D., Jaffe C.L., Burshtain O., Gonen L., Baneth G., Polymerase chain reaction using noninvasively obtained samples, for the detection of Leishmania infantum DNA in dogs, J. Infect. Dis. (2004) 189:1729-1733 [CrossRef] [PubMed].
  41. Strauss-Ayali D., Baneth G., Shor S., Okano F., Jaffe C.L., Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs, Int. J. Parasitol. (2005) 35:63-73 [CrossRef] [PubMed].
  42. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., Barral A., Chemokines in host-parasite interactions in leishmaniasis, Trends Parasitol. (2005) 22:32-40 [CrossRef] [PubMed].
  43. Wortmann G., Sweeney C., Houng H.S., Aronson N., Stiteler J., Jackson J., Ockenhouse C., Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction, Am. J. Trop. Med. Hyg. (2001) 65:583-587 [PubMed].
  44. Zaph C., Scott P., Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major, Infect. Immun. (2003) 71:1587-1589 [CrossRef] [PubMed].